Our Vision
Cliniphai is a technology company dedicated to developing AI Agents, Frameworks, and Workflow Platforms that empower life science companies to fully harness the benefits of the technological revolution. Our flagship product, Athena, addresses the complex challenges of translation and localization within the life sciences industry, enabling seamless communication and compliance in global markets
Meet Our Leadership Team
Jason Martin
Chairman
Jason Martin is the Managing Partner and Co-Founder of Cliniphai, bringing nearly 30 years of experience in pharmaceutical R&D, clinical research, and data science. He currently serves as Vice President, Digital Technologies at NAMSA. Jason has held senior roles at leading clinical research organizations, driving innovation in clinical trial technology. He holds advanced degrees in Biochemistry, Bioorganic Chemistry, and an executive MBA.
Dr. Vladimir Mats
CEO
Vladimir Mats is a co-founder and CEO of Cliniphai, with over 25 years of experience in statistical analysis and clinical data management across the pharmaceutical, biotechnology, and medical device industries. He previously co-founded Quartesian, a global clinical research organization (CRO), and served as Senior Vice President at Veranex. Vladimir holds a PhD in Biostatistics from the University of Maryland, Baltimore, making him instrumental in advancing Cliniphai’s mission
Dr. Yuri Kartashov
Advisor, Research & Development
Yuri Kartashov, co-founder of Cliniphai, holds a PhD in Probability Theory and Statistics and has over 20 years of experience in software development, technology leadership, and innovation management. His expertise includes mathematics, data science, deep learning, and statistical modeling, specializing in scalable software solutions for clinical research and healthcare technology.